Skip to main content
Log in

Serum and fecal pancreatic enzymes in beta-thalassemia major

  • Original Articles
  • Published:
International Journal of Pancreatology Aims and scope Submit manuscript

Summary

Conclusion

This study, using indirect tests, demonstrated that exocrine pancreatic function is impaired in a proportion of patients with beta-thalassemia major (TM), though this impairment is generally mild or moderate.

Background

Impaired structure and function of the exocrine pancreas has been reported in patients with Beta-thalassemia major.

Methods

In this study we measured fecal fats and serum and fecal pancreatic enzymes in 30 patients (13 M, 17 F) with TM, mean age 22.1 yr (range 14–39) and compared them with those of a matched group of healthy controls. Results were correlated with age, serum ferritin, blood transfusion, and various nutritional parameters. Enzymes assays included: serum pancreatic amylase (PA), lipase (L), trypsin (T), fecal chymotrypsin (FCT), and fecal elastase (FE).

Results

No patient was positive for steatorrhea. Comparison of the mean values showed a significant difference only for FE (p<0.002). Using only the fecal tests as a reference, we found that 12 patients had FE values below the cutoff limit; of these, five had values between 100 and 185 μg/g, three between 50 and 99 μg/g and four below 50 μg/g. Ten patients had FCT values below the cutoff limit; seven presented impairment in both tests and six of them had FE values below 100 μg/g (including four diabetics). No correlations were found between enzyme values and mean serum ferritin values or mean blood consumption over the previous 3 yr. No correlation was found between FE and FCT levels or between enzymes and age.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Ellis JT, Schulman I, Smith CH. Generalized siderosis with fibrosis of liver and pancreas in Cooley’s anemia.Am J Pathol 1954; 30: 287–303.

    PubMed  CAS  Google Scholar 

  2. Gullo L, Corcioni E, Brancati C, Bria M, Pezzilli R, Sprovieri G. Morphologic and functional evaluation of the exocrine pancreas in beta-thalassemia major.Pancreas 1993; 8: 176–180.

    Article  PubMed  CAS  Google Scholar 

  3. Gullo L, Costa PL, Fontana G, Labò G. Investigation of exocrine pancreatic function by continuous infusion of cerulein and secretin in normal subjects and in chronic pancreatitis.Digestion 1976; 14: 97–107.

    PubMed  CAS  Google Scholar 

  4. Lankisch PG, Brauneis J, Otto J, Goke B. Pancreolauryl test and NBT-PABA tests: Are serum tests more practicable alternatives to urine tests in the diagnosis of exocrine pancreatic insufficiency?Gastroenterology 1986; 90: 350–354.

    PubMed  CAS  Google Scholar 

  5. Amman R, Tagwercher E, Kashiwagi H, Rosemund N. Diagnostic value of fecal chymotrypsin and trypsin assessment for detection disease. A comparative study.Am J Dig Dis 1968; 13: 123–128.

    Article  Google Scholar 

  6. Carroccio A, Iacono G, Marino G, Montalto G, Notarbartolo A. Fecal chymotrypsin: clinical evaluation of the paranitroaniline assay.J Lab Med 1986; 13: 247–249.

    Google Scholar 

  7. Ventrucci M, Gullo L, Daniele C, et al. Comparative study of serum pancreatic isoamylase, lipase and trypsin-like immunoreactivity in pancreatic disease.Digestion 1983; 28: 114–121.

    PubMed  CAS  Google Scholar 

  8. Dominguez-Munoz JE, Hieronimus C, Sauerbrug T, Malfertheiner P. Fecal elastase test: evaluation of a new noninvasive pancreatic function test.Am J Gastroenterol 1995; 90: 1834–1837.

    PubMed  CAS  Google Scholar 

  9. Stein J, Jung M, Sziegoleit A, Zeuzem S, Gaspary W, Lembcke B. Immunoreactive elastase 1. clinical evaluation of new noninvasive test of pancreatic function.Clin Chem 1996; 42: 222–226.

    PubMed  CAS  Google Scholar 

  10. Loser Chr, Mollgaard A, Folsch UR. Fecal elastase 1. a novel highly sensitive and specific tubeless pancreatic function test.Gut 1996; 39: 580–586.

    Article  PubMed  CAS  Google Scholar 

  11. Phuapradit P, Narang A, Mendonca P, Harris DA, Baum JD. The steatocrit: a simple method for estimating stool fat content in newborn infants.Arch Dis Child 1981; 56: 725–728.

    PubMed  CAS  Google Scholar 

  12. Iacono G, Carroccio A, Montalto G, Cavataio F, Balsamo V, Notarbartolo A. Steatocrit test after a standard fatty meal: a new simple and sensitive test to detect malabsorption.J Ped Gastroenterol Nutr 1991; 13: 161–167.

    Article  CAS  Google Scholar 

  13. Hussain M, Dandona P, Fedail SS, Ramdial L, Flynn D, Hoffbrand AV. Serum immunoreactive trypsin in beta-thalassemia major.J Clin Pathol 1981; 34: 970,971.

    Article  PubMed  CAS  Google Scholar 

  14. Junglee D, Katrak A, Hoffbrand AV, Dandona P. Pancreatic lipase in serum of patients with beta-thalassemia major.Clin Chem 1983; 29: 2003,2004.

    PubMed  CAS  Google Scholar 

  15. Erttmann R, Hausdorf G, Landback G. Pancreatic sonography in thalassemia major.Klin Pediatr 1983; 55: 97–99.

    Article  Google Scholar 

  16. Di Magno EP, Go VLW, Summerskill WHJ. Relations between pancreatic enzymes outputs and malabsorption in severe pancreatic insufficiency.N Engl J Med 1973; 288: 813–815.

    Article  Google Scholar 

  17. Sziegolei A, Linder D. Die menschliche pankreaselastase 1. biochemische und klinische aspekte.Med Welt 1991; 42: 682–684.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Montalto, G., D’Angelo, P., Lo Casto, A. et al. Serum and fecal pancreatic enzymes in beta-thalassemia major. International Journal of Pancreatology 22, 131–135 (1997). https://doi.org/10.1007/BF02787471

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02787471

Key Words

Navigation